Nothing Special   »   [go: up one dir, main page]

Olson, 1993 - Google Patents

Reparative strategies in the brain: treatment strategies based on trophic factors and cell transfer techniques

Olson, 1993

Document ID
11715286611897574478
Author
Olson L
Publication year
Publication venue
Advances in Stereotactic and Functional Neurosurgery 10: Proceedings of the 10 th Meeting of the European Society for Stereotactic and Functional Neurosurgery Stockholm 1992

External Links

Snippet

Three reparative strategies based on transfer of genes, molecules, or cells to the central nervous system are reviewed. When neurons are already lost, they can sometimes be replaced by transfer to the target area of neurons or other cells compensating for the lost …
Continue reading at link.springer.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue

Similar Documents

Publication Publication Date Title
Olson Regeneration in the adult central nervous system: experimental repair strategies
Connor et al. The role of neuronal growth factors in neurodegenerative disorders of the human brain
Collier et al. Therapeutic potential of nerve growth factors in Parkinson’s disease
Terenghi Peripheral nerve regeneration and neurotrophic factors
Hefti Neurotrophic factor therapy for nervous system degenerative diseases
Mocchetti et al. Neurotrophic factors in central nervous system trauma
Tomlinson et al. Role of neurotrophins in diabetic neuropathy and treatment with nerve growth factors
Lu et al. Neurotrophism without neurotropism: BDNF promotes survival but not growth of lesioned corticospinal neurons
Krieglstein Factors promoting survival of mesencephalic dopaminergic neurons
Shoichet et al. Cell delivery to the central nervous system
Castillo Jr et al. Retinal ganglion cell survival is promoted by genetically modified astrocytes designed to secrete brain-derived neurotrophic factor (BDNF)
Thanos et al. Ultrastructure and cellular biology of nerve regeneration
Bray et al. Neuronal and Nonneuronal Influences on Retinal Ganglion Cell Survival, Axonal Regrowth, and Connectivity after Axotomy a
Tuszynski et al. Central infusions of brain-derived neurotrophic factor and neurotrophin-45, but not nerve growth factor and neurotrophin-3, prevent loss of the cholinergic phenotype in injured adult motor neurons
Oppenheim The concept of uptake and retrograde transport of neurotrophic molecules during development: history and present status
Hefti et al. Neurotrophic factors: what are they and what are they doing
Miwa et al. Role of nerve growth factor in the olfactory system
Tuszynski et al. Neurotrophic factors and diseases of the nervous system
Olson Reparative strategies in the brain: treatment strategies based on trophic factors and cell transfer techniques
Seeburger et al. Experimental rationale for the therapeutic use of neurotrophins in amyotrophic lateral sclerosis
Hefti et al. Protective effects of nerve growth factor and brain-derived neurotrophic factor on basal forebrain cholinergic neurons in adult rats with partial fimbrial transections
Chadi et al. Analysis of trophic responses in lesioned brain: focus on basic fibroblast growth factor mechanisms
Tannemaat et al. The application of viral vectors to enhance regeneration after peripheral nerve repair
Olson Grafts and growth factors in CNS: basic science with clinical promise
Vantini The pharmacological potential of neurotrophins: a perspective